Literature DB >> 26551070

Limited Added Value of the Posterolateral Approach.

Sarah N Pierrie1, Luke S Harmer2, Madhav A Karunakar1, Marc R Angerame1, Erica B Andrews3, Katherine M Sample3, Joseph R Hsu1.   

Abstract

BACKGROUND: Posterolateral tibial plateau fractures (AO/OTA 41-B or 41-C) represent a minority of proximal tibia fractures. Numerous surgical approaches have been described, each with unique variations and limitations. The purpose of this study is to quantitatively and qualitatively compare the surface area and structures exposed by four surgical approaches to the posterolateral proximal tibia.
METHODS: Four published surgical approaches-direct posterolateral (DPL), transfibular (TF), posteromedial (PM), and anterolateral (AL)-were performed on 10 fresh-frozen cadavers. Once each exposure was obtained, a ruler was placed in the surgical field and calibrated digital images obtained. Overall, 10 bony and soft tissue landmarks were identified and the surgeon's ability to see or touch each landmark was recorded sequentially for each exposure.
RESULTS: An average of 3.9 ± 2.7 cm(2) of posterolateral proximal tibial cortex was exposed by the DPL approach with significantly more surface area exposed by the TF, PM, and AL approaches (p < 0.01). The AL and PM approaches revealed a significantly larger area of tibial metaphysis and, when used together, consistently exposed posterior metaphyseal and intra-articular structures.
CONCLUSION: A combination of the AL and PM approaches allows comparable surgical exposure to the proximal tibial when compared with two posterolateral approaches. These approaches can be employed together for reduction and fixation of injuries to the posterolateral tibial plateau and allow direct evaluation of the articular surface. Dedicated posterolateral approaches should be reserved for certain clinical situations, including proximal tibiofibular joint fracture or dislocation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26551070     DOI: 10.1055/s-0035-1564597

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  6 in total

1.  Comparison Between Treatment of Bicondylar Tibial Plateau Fractures With or Without Posterolateral Fragments Using Posteromedial and Anterolateral Approaches.

Authors:  Shinichiro Okimura; Hideto Irifune; Shutaro Fujimoto; Atsushi Teramoto; Toshihiko Yamashita
Journal:  Indian J Orthop       Date:  2022-05-29       Impact factor: 1.033

2.  Posterior tibial plateau fracture treatment with the new WAVE posterior proximal tibia plate: feasibility and first results.

Authors:  Juriaan Van den Berg; Maike Reul; Olivier Vinckier; Robert Jan Derksen; Stefaan Nijs; Michiel Verhofstad; Harm Hoekstra
Journal:  Eur J Trauma Emerg Surg       Date:  2021-03-12       Impact factor: 3.693

3.  Surgical Treatment of Lateral Tibial Plateau Fractures Involving the Posterolateral Column.

Authors:  Qi-Jie Shen; Jin-Li Zhang; Guo-Sheng Xing; Zhong-Yu Liu; En-Qi Li; Bao-Cheng Zhao; Yu-Chen Zheng; Qing Cao; Tao Zhang
Journal:  Orthop Surg       Date:  2019-11-06       Impact factor: 2.071

4.  [Application of modified anterolateral supra-fibular-head approach in treatment of tibial plateau fractures involving posterolateral column].

Authors:  Bo Zu; Jianjun Wang; Jinrui Liu; Zhi Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-06-15

5.  Treatment of posterolateral tibial plateau fractures with a rotational support plate and special pressurizer: technical note and retrospective case series.

Authors:  Yu-Feng Chen; Dong Ren; Lin-Dan Geng; Shuang-Quan Yao; Zhao-Hui Song; Liang Guang; Tian-Ci Wang; Peng-Cheng Wang
Journal:  J Orthop Surg Res       Date:  2021-06-23       Impact factor: 2.359

6.  Tibial plateau fractures in elderly people: an institutional retrospective study.

Authors:  Qi-Fang He; Hui Sun; Lin-Yuan Shu; Yu Zhan; Chun-Yan He; Yi Zhu; Bin-Bin Zhang; Cong-Feng Luo
Journal:  J Orthop Surg Res       Date:  2018-11-01       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.